MedTrace Logo

Japan Early Diabetes Intervention Study

NCT00464594 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2560

Last updated 2007-04-24

No results posted yet for this study

Summary

The purpose of this study is to compare the suppressive effect of two kinds of interventions on the worsening/progression to definite diabetes: standard lifestyle guidance and standard lifestyle guidance combined with pharmacological intervention (monotherapy with one of acarbose, metformin, or gliclazide).

Conditions

Interventions

BEHAVIORAL

Standard lifestyle guidance

DRUG

Lifestyle guidance and monotherapy with acarbose

DRUG

Lifestyle guidance and monotherapy with metformin

DRUG

Lifestyle guidance and monotherapy with gliclazide

Sponsors & Collaborators

  • Japan Early Diabetes Intervention Study Group

    lead OTHER

Principal Investigators

  • Takeshi Kuzuya · Jichi Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00464594 on ClinicalTrials.gov